Health
Vaccine by Christmas amid record cases in the US – News Mail
The Oxford vaccine trial has produced a positive response, as more than half US states reported their highest day of new cases.
A vaccine candidate for COVID-19 developed by the University of Oxford with the backing of pharmaceutical giant AstraZeneca has produced positive results.
The test jabs have triggered robust immune responses in adults.
According to Bloomberg, findings from blood tests which were carried out on a group of older trial participants reinforce data released in July which suggest the vaccine is effective for adults aged between 18 and 55, Astra announced on Monday local time.
Results from the study show…
-
General22 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General22 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Noosa News23 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
Noosa News14 hours agoSunshine Coast police disappointed by drink drivers in school zone